Last edition
News about "atrial fibrillation pipeline"
Quotient and Acesion Partner on AI-Enhanced Formulation Development
Quotient Sciences and Acesion Pharma have partnered on AI-enhanced formulation development to accelerate early clinical decisions for atrial fibrillation treatments.
Atrial Fibrillation Pipeline | 05/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members